Jasenka Piljac Žegarac

PhD

Jasenka is a scientist and professional freelance medical writer with expertise in a wide range of therapeutic and scientific areas. Her research articles have gathered more than 1200 citations. At The Scientist Writer LLC, she helps clients from the food, pharma, and biotech industries develop top-quality communications solutions. Find Jasenka on LinkedIn.

Most Recent Articles by Jasenka Piljac Žegarac

SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights

SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights

By

Dr Bush discusses the combination of SGLT2 inhibitors and GLP-1 receptor agonist for the treatment of type 2 diabetes.

Medication Adherence in Youth With Type 2 Diabetes: Latest Insights

Medication Adherence in Youth With Type 2 Diabetes: Latest Insights

By

Barriers and strategies for medication adherence in youth with type 2 diabetes were found to be similar to those observed in youth with other chronic pediatric conditions.

 Blood Pressure Targets in Type 2 Diabetes: Latest Research

Blood Pressure Targets in Type 2 Diabetes: Latest Research

By

Experts call on healthcare providers to diligently focus on hypertension as an important comorbid condition that is strongly associated with adverse cardiovascular outcomes, including death.

Managing Menopausal Symptoms in Breast Cancer Survivors

Managing Menopausal Symptoms in Breast Cancer Survivors

By

Lifestyle modification and an individualized treatment approach are effective strategies for managing menopausal symptoms in breast cancer survivors who are largely advised to avoid hormone replacement therapy.

Thyroid Dysfunction Not a Risk Factor for Carotid Plaque Development

Thyroid Dysfunction Not a Risk Factor for Carotid Plaque Development

By

Subclinical thyroid dysfunction did not influence the cumulative incidence of new carotid plaques in healthy individuals aged 20 or older.

Sign Up for Free e-Newsletters



CME Focus